Christopher F. Wyatt - 10 Feb 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Reporting relationship: SVP & Controller
Issuer ticker: HCA
Reported as of: 10 Feb 2026
Net transaction value: -$2,539,120
SEC form: 4
Accepted by SEC: 12 Feb 2026, 18:55:42 UTC
Prior SEC filing: 09 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Kevin A. Ball, Attorney-in-Fact

Key filing fact

Christopher F. Wyatt filed Form 4 for HCA Healthcare, Inc. (HCA) on 12 Feb 2026.

Key facts

This page summarizes Christopher F. Wyatt's Form 4 filing for HCA Healthcare, Inc. (HCA).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 Feb 2026, 18:55.

Change

Previous filing in this sequence was filed on 09 Feb 2026.
Current net transaction value: -$2,539,120.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673365 Primary reporting owner

Wyatt Christopher F.

Relationship: SVP & Controller
Address: ONE PARK PLAZA, NASHVILLE
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Signature date: 12 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Award

Transaction value: $0
Shares: +3,350
Change %: +7.3%
Price: $0.000000
Shares after: 49,413
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F1

HCA transaction

Common Stock

Tax liability

Transaction value: $519,120
Shares: -1,034
Change %: -2.1%
Price: $502.05
Shares after: 48,379
Date: 10 Feb 2026
Ownership: Direct

HCA transaction

Common Stock

Sale

Transaction value: $2,020,000
Shares: -4,000
Change %: -8.3%
Price: $505.00
Shares after: 44,379
Date: 11 Feb 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On January 30, 2023, the reporting person was granted 1,675 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.